Roundview Capital LLC Abbott Laboratories Transaction History

Roundview Capital LLC

$1.25 Billion
Q2 2024

A detailed history of Roundview Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Roundview Capital LLC holds 10,370 shares of ABT stock, worth $1.18 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

10,370

Previous 11,040 6.07%

Holding current value

$1.18 Million

Previous $1.25 Million 14.11%

% of portfolio

0.09%

Previous 0.1%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $67,489 - $75,334	-670 Reduced 6.07%	10,370 $1.08 Million
Q1 2024 May 06, 2024	BUY	$109.52 - $120.96 $157,818 - $174,303	1,441 Added 15.01%	11,040 $1.25 Million
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $101,734 - $124,531	1,128 Added 13.32%	9,599 $1.06 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $955 - $1,146	-10 Reduced 0.12%	8,471 $820,000
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $934,129 - $1.04 Million	-9,269 Reduced 52.22%	8,481 $924,000
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $59,181 - $69,660	611 Added 3.56%	17,750 $1.8 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $34,601 - $40,593	364 Added 2.17%	17,139 $1.88 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $71,021 - $82,230	734 Added 4.58%	16,775 $1.62 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $44,604 - $53,912	437 Added 2.8%	16,041 $1.74 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $10,375 - $12,652	-91 Reduced 0.58%	15,604 $1.85 Million
Q4 2021 Feb 10, 2022	SELL	$115.53 - $141.46 $163,243 - $199,882	-1,413 Reduced 8.26%	15,695 $2.21 Million
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $268,667 - $297,225	2,303 Added 15.56%	17,108 $2.02 Million
Q2 2021 Aug 10, 2021	SELL	$105.79 - $124.53 $17,878 - $21,045	-169 Reduced 1.13%	14,805 $1.72 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $26,665 - $31,416	245 Added 1.66%	14,974 $1.8 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $71,820 - $78,263	684 Added 4.87%	14,729 $1.61 Million
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $625,809 - $759,999	6,829 Added 94.64%	14,045 $1.53 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $32,465 - $41,552	424 Added 6.24%	7,216 $660,000
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $20,542 - $30,038	327 Added 5.06%	6,792 $536,000
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $145,832 - $170,085	-2,001 Reduced 23.64%	6,465 $543,000
Q1 2019 May 09, 2019	BUY	$66.22 - $80.06 $7,151 - $8,646	108 Added 1.29%	8,466 $677,000
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $137,872 - $156,189	2,103 Added 33.62%	8,358 $605,000
Q3 2018 Nov 07, 2018	SELL	$60.81 - $73.36 $3,952 - $4,768	-65 Reduced 1.03%	6,255 $459,000
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $104,099 - $117,697	-1,850 Reduced 22.64%	6,320 $379,000
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $5,368 - $5,747	-100 Reduced 1.21%	8,170 $466,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $10,813 - $12,069	225 Added 2.8%	8,270 $441,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $386,642 - $431,533	8,045	8,045 $391,000

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roundview Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roundview Capital LLC with notifications on news.

Account

Roundview Capital LLC Abbott Laboratories Transaction History